Evaluation of 177Lu-CHX-A′′-DTPA-Bevacizumab as a radioimmunotherapy agent targeting VEGF expressing cancers

Mythili Kameswaran, Usha Pandey, Naresh Gamre, K.V. Vimalnath, Haladhar Dev Sarma, Ashutosh Dash
  • Applied Radiation and Isotopes, August 2016, Elsevier
  • DOI: 10.1016/j.apradiso.2016.05.025
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Haladhar Dev Sarma